Email updates

Keep up to date with the latest news and content from DARU Journal of Pharmaceutical Sciences and BioMed Central.

Open Access Highly Accessed Editorial

Safety concerns to application of graphene compounds in pharmacy and medicine

Mehdi Mogharabi12, Mohammad Abdollahi2 and Mohammad Ali Faramarzi1*

Author Affiliations

1 Department of Pharmaceutical Biotechnology, Faculty of Pharmacy & Biotechnology Research Center, Tehran University of Medical Sciences, Tehran 1417614411, Iran

2 Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1417614411, Iran

For all author emails, please log on.

DARU Journal of Pharmaceutical Sciences 2014, 22:23  doi:10.1186/2008-2231-22-23

Published: 22 January 2014

Abstract

Graphene, the new allotrope of carbon is a single layer of monocrystalline graphite with sp2 hybridized carbon atoms. This compound has received worldwide attention due to its extraordinary physical and chemical properties. Duo to the widespread application of geraphenes, concerns are raising about its environmental safety or the safety protocols for handling and waste of graphene-based materials. The generation of reactive free radicals, adsorption of important biomolecules, and physical toxicity of graphene also matter. Hereby we criticize the concerns on the toxicity of graphenes to provide some perspective on the potential hazards of future development in graphene-based biomaterials.

Keywords:
Graphene; Graphene oxide; Membrane; Reactive oxygen species; Safety; Toxicity